Baird has lowered its rating on UnitedHealth, moving from "Outperform" to "Neutral" thanks to a gnarly Medicare model shift.

Mastercard transformed the UEFA Champions League Final into a thrilling, VIP experience for its Ghanaian cardholders through ...

Greenwood Capital Associates boosted its Exxon Mobil investment by buying 9,305 more shares, now holding a total of 75,697.

AbbVie’s price target got a fresh boost as Citigroup raised it to $205, joining a chorus of analysts expressing optimism.

Fortitude Family Office dramatically reduced its Procter & Gamble stake by over 50% in Q1, selling nearly 2,800 shares. Their ...

Greenwood Capital Associates sold 21.9% of its Johnson & Johnson holdings in Q1, reducing their stake by over 15,000 shares.

Oracle just dropped its fiscal 2025 curtain and is already hyping fiscal 2026 with cloud-powered ambition. Morgan Stanley ...

Berkshire Hathaway’s energy portfolio is a tale of two strategies—one bold, one beautifully boring—and the latter is winning ...

Costco continues to defy retail gravity with a rock-solid membership model, efficient operations, and e-commerce hustle. The ...

Merck shares fell 1.27%, lagging behind the S&P 500’s smaller dip of 0.27%. This decline comes despite Merck’s prior ...

Vest Financial raised its stake in Wells Fargo by 73.5%, buying 11,547 more shares and now holding 27,256 worth $1.96 million ...

Salesforce just turned some analyst heads with a forecasted earnings-per-share of $8.55 for FY2026, outpacing consensus by ...